Pet Service Holding H1 2026: Revenue Up to €7.36M, Net Loss Widens

Pet Service Holding Seeks Up to €4 Million Capital Injection Amid Regulatory Friction and Widening Net Losses

WORMERVEER, Netherlands — Dutch companion animal health and retail distribution operator Pet Service Holding NV reported its half-year (H1) 2026 financial performance, delivering top-line growth alongside a widening net loss. To stabilize its balance sheet and protect growth initiatives, the company is preparing a private placement of up to €4.0 million alongside debt conversion measures.

Financial Snapshot: H1 2026 Performance

Despite operational revenue expansion and gross margin improvement, the company’s net loss widened significantly to €908,000 from €560,000 in the prior-year period.

Holding Costs and Regulatory Obstacles

A critical structural detail in the release lies in the gap between Operating-Business EBITDA (€30,000) and Group EBITDA (−€226,000). While underlying retail and distribution operations generated positive earnings, overhead and holding-company expenses dragged consolidated performance into negative territory.

Management highlighted severe operational headwinds stemming from regulatory enforcement surrounding online prescription veterinary medicines. Interpretation and enforcement by the Dutch food and consumer product safety authority (NVWA) directly impacted online prescription sales channels, forcing strategic adjustments across the company’s veterinary pharma distribution network.

Additionally, Pet Service Holding is actively pursuing €2.07 million in legal claims against the former sellers and shareholders of Asklepios. The company emphasizes that these allegations remain subject to ongoing legal proceedings and do not constitute established findings of fraud.

Refinancing and Balance Sheet Restructuring

To restore positive equity before the conclusion of the fiscal year, Pet Service Holding is structuring a dual-track financing strategy:

1. Private Equity Placement: Seeking between €3.5 million and €4.0 million in fresh capital.

2. Debt-to-Equity Conversion: Converting approximately €1.025 million in outstanding convertible bonds into equity.

Neither financing mechanism is reported as finalized. Despite current balance-sheet pressures, management reaffirmed its full-year 2026 revenue guidance of €17.0 million to €18.0 million. Long-term ambitions targeting €50 million in revenue by 2029–2030 remain conditional on capital execution and market stability rather than near-term financial guidance.

Analyst Takeaway

Pet Service Holding’s latest figures illustrate the broader pressures impacting digital veterinary pharmacy platforms across Europe. While gross margins remain healthy at 35%, stringent regulatory oversight on online prescription channels combined with corporate holding overhead continues to test operating leverage. Successful execution of the pending private placement will be necessary to resolve equity deficits and maintain long-term expansion plans.